Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110015999B enables metal-free triazole synthesis with high purity and simplified scale-up for pharmaceutical intermediates.
Patent CN114539198B enables cost-effective fine chemical production through nitroarene-based aminocarbonylation with simplified purification and broad functional group tolerance.
Patent CN114213298B enables high-purity thiosulfonate synthesis through air oxidation, delivering significant cost reduction and reliable supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN115286578B enables metal-free production of high-purity pyrazole intermediates, reducing lead time and manufacturing costs for pharmaceutical applications.
Patent CN102746343B enables high-yield asymmetric synthesis of trifluoromethyl propargyl alcohols with >95% ee, reducing lead time and costs in pharmaceutical intermediate production.
Patent CN116199614B introduces a novel chiral indole-pyrrole synthesis with high enantioselectivity and mild conditions, offering significant cost reduction and supply chain advantages for pharmaceutical intermediates.
Novel palladium-catalyzed method using nitroarenes enables cost-effective production of high-purity (iso)chroman amides with improved supply chain reliability.
Patent CN102276376B introduces an efficient synthesis route eliminating chiral resolution, enhancing purity and reducing supply chain costs for pharmaceutical intermediates.
Patent CN106187656B enables >99% selective monoarylation under mild conditions, reducing costs and lead times for high-purity fine chemicals.
Novel palladium-catalyzed method using nitroarenes as nitrogen source enables high-purity chromane amide production with simplified supply chain and reduced manufacturing costs.
Innovative benzofuran-based phosphine ligand enables high-yield Suzuki-Miyaura coupling with simplified synthesis, reducing manufacturing costs and improving supply chain reliability for fine chemicals.
Patent CN103804268B enables room-temperature enamine synthesis with high regioselectivity, reducing manufacturing costs and lead times for pharmaceutical intermediates through simplified catalysis.
Patent CN108727189B enables high-purity chiral recognition with streamlined synthesis, reducing supply chain risks for pharmaceutical intermediates.
Patent CN114436949B enables mild ester hydrogenation with high stability, reducing catalyst costs and improving supply chain reliability for fine chemical manufacturing.
Patent CN102060779B enables high-yield synthesis of diverse 2-aminobenzimidazole derivatives with simplified purification, reducing lead time and manufacturing costs for pharmaceutical applications.
Patent CN113121462B enables safer triazole synthesis with improved purity and reduced manufacturing costs for pharmaceutical applications.
Patent CN110615811A enables high-purity chiral ligand synthesis via crystallization method eliminating column chromatography thus reducing manufacturing costs and improving supply chain reliability.
Patent CN107857729B enables green synthesis of iodinated pyrazoles with mild conditions and high yields, enhancing supply chain reliability for pharmaceutical intermediates.
Patent CN114195726B enables cost-effective synthesis of triazolyl arylamines through copper-catalyzed decarbonylation with simplified supply chain operations.
Patent CN112159312B enables high-purity triarylmethane synthesis through novel catalytic cascade, reducing lead time and production costs for pharmaceutical intermediates.